Cargando…
Suppression of Immunotherapy on Group 2 Innate Lymphoid Cells in Allergic Rhinitis
BACKGROUND: Group 2 innate lymphoid cells (ILC2s) are regarded as a novel population of lineage-negative cells that induce innate Type 2 responses by producing the critical Th2-type cytokines interleukin (IL)-5 and IL-13. ILC2s as key players in the development of allergic rhinitis (AR) have been pr...
Autores principales: | Fan, Da-Chuan, Wang, Xiang-Dong, Wang, Cheng-Shuo, Wang, Yang, Cao, Fei-Fei, Zhang, Luo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146790/ https://www.ncbi.nlm.nih.gov/pubmed/27900996 http://dx.doi.org/10.4103/0366-6999.194642 |
Ejemplares similares
-
The Inhibition of Group II Innate Lymphoid Cell Response by IL-27 in Allergic Rhinitis
por: Luo, Xi, et al.
Publicado: (2020) -
CD226 Deficiency Alleviates Murine Allergic Rhinitis by Suppressing Group 2 Innate Lymphoid Cell Responses
por: Xie, Yang, et al.
Publicado: (2022) -
Changes in type 2 innate lymphoid cells and serum cytokines in sublingual immunotherapy in pediatric patients with allergic rhinitis
por: Wang, Xiaoqiang, et al.
Publicado: (2023) -
High density lipoprotein inhibited group II innate lymphoid cells proliferation and function in allergic rhinitis
por: Gao, Shengli, et al.
Publicado: (2022) -
Group 2 Innate Lymphoid Cells in Respiratory Allergic Inflammation
por: Helfrich, Sofia, et al.
Publicado: (2019)